IL22 and polycystic ovary syndrome: After giving the PCOS-like mice GDCA or interleukin (IL)-22 treatment, hormone abnormalities, estrous cycle disorders, polycystic ovaries, decreased fertility, and insulin resistance were significantly improved (Qi et al., 2019).